Adams Looks To Mucinex Extensions; “Mr. Mucus” Marries
This article was originally published in The Tan Sheet
Executive Summary
Adams Respiratory Therapeutics sees additions to its Mucinex extended-release guaifenesin line as "key" to the firm's long-term growth strategy
You may also be interested in...
Adams Brings Mucinex To Pediatric Market; Humibid Launch Slated For March
Adams Respiratory Therapeutics will launch a line of cough/cold products for children under the Mucinex brand name by the end of 2006
Adams Brings Mucinex To Pediatric Market; Humibid Launch Slated For March
Adams Respiratory Therapeutics will launch a line of cough/cold products for children under the Mucinex brand name by the end of 2006
Adams Brings Mucinex To Pediatric Market; Humibid Launch Slated For March
Adams Respiratory Therapeutics will launch a line of cough/cold products for children under the Mucinex brand name by the end of 2006